On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.
"So we built the seatbelts before the car, so to speak, wherein we did a project to figure out ways to biocontain these organisms....
“Our studies are open for those that have exhausted standard of care, and we're showing improved responses, and the data is promising. So, I...
How do you obtain the best possible patient care available? On this week's Few & Far Between podcast, host Chris O'Brien welcomes patient advocacy...